Next Generation Platform Velocity

Velocity was built by starting where trials actually happen: with sponsors, sites, and patients. After six months analyzing real-world workflows across existing RTSM systems, the platform was redesigned end to end to reflect how studies are truly built, tested, and run day to day. A standout capability allows teams to build and test studies in parallel, reducing UAT time, minimizing surprises, and keeping sponsors actively involved rather than waiting for handoffs.

Velocity continually shortens timelines from award to release while maintaining quality, including rapid implementation of protocol amendments so changes are live ahead of first patient in. A sponsor-specific data view enables portfolio-level visibility across studies, with reusable templates that scale consistently. Core functionality spans randomization and trial supply management, enhanced by advanced capabilities such as central pharmacy workflows, multidose handling, forecasting, and flexible supply strategies.

AI-powered ELO features elevate the platform further, transforming data into actionable guidance. From deeper insight during study design to conversational access to supply chain data, AI helps teams make smarter decisions, optimize protocols, and improve site usability. The result is a differentiated platform designed to help trials run faster, smarter, and with greater confidence. Explore how Velocity supports faster paths from protocol to patient.